Committee for medicinal products for human use (CHMP) – Meeting Minutes 19-22 June 2017
The minutes include the following topics: Oral Explanations, Initial applications, Extension of marketing authorisation according to Annex I of Commission Regulation (EC) No 1234/2008, Type II variations, Ancillary medicinal substances in medical devices, Procedure under Article 83(1) of Regulation (EC) 726/2004, Pre-submission issues, Post-authorisation issues, Referral procedures, Pharmacovigilance issue, Inspections, Innovation Task Force, and Organisational, regulatory and methodological matters.
#CommitteeforMedicinalProducts #RegulatoryAffairs #Clinical #Pharmacovigilance
